Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-21 Purchase | 2025-08-29 4:55 pm | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 21,000 | $0.93048 | $19,540 | 298,574 (Direct) | View |
| 2025-06-23 Purchase | 2025-06-25 4:30 pm | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer President & CEO | 6,146 | $1.1585 | $7,120 | 277,574 (Direct) | View |
| 2025-06-20 Purchase | 2025-06-24 4:30 pm | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer President & CEO | 10,000 | $1.2 | $12,000 | 271,428 (Direct) | View |
| 2025-06-17 Purchase | 2025-06-20 4:05 pm | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer President & CEO | 15,000 | $1.2 | $18,000 | 261,428 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A 2036-08-18 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 45,000 | $0 | 121,861 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 12,312 | $7.899 | 121,861 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A 2036-08-18 | Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner | 45,000 | $0 | 185,805 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner | 23,409 | $7.899 | 185,805 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 10,052 | $16.16 | 98,877 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 10,052 | $0.0004 | 98,877 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A 2036-08-18 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 60,000 | $0 | 98,877 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 16,413 | $7.899 | 98,877 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 3,866 | $16.16 | 82,759 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 3,866 | $0.0004 | 82,759 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A 2036-08-18 | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 60,000 | $0 | 82,759 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 17,777 | $7.899 | 82,759 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 27,066 | $16.16 | 215,173 (Direct) | View |
| 2026-10-14 Exercise | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 27,066 | $0.0004 | 215,173 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A 2036-08-18 | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 174,000 | $0 | 215,173 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A 2036-08-18 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 45,000 | $0 | 57,102 (Direct) | View |
| 2026-08-18 Option Award | 2026-10-16 5:20 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 8,536 | $7.899 | 57,102 (Direct) | View |
| 2026-10-12 Option Award | 2026-10-14 5:21 pm | N/A 2036-10-05 | Akari Therapeutics Plc | AKTX | Vat-Ho Vatnak Chief Business Officer | 87,000 | $0 | 87,000 (Direct) | View |
| 2026-09-29 Option Award | 2026-10-01 4:50 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 6,430 | $9.72 | 14,107 (Direct) | View |
| 2026-08-17 Option Award | 2026-08-19 5:00 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 1,728 | $7.52 | 23,309 (Direct) | View |
| 2026-07-16 Option Award | 2026-08-05 6:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 1,130 | $11.5 | 21,581 (Direct) | View |
| 2026-07-07 Exercise | 2026-07-17 06:03 am | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director 10% Owner | 21,265 | $16.16 | 101,807 (Indirect) | View |
| 2026-07-07 Exercise | 2026-07-17 06:03 am | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director 10% Owner | 21,265 | $0.0004 | 101,807 (Indirect) | View |
| 2026-07-07 Exercise | 2026-07-17 06:03 am | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director 10% Owner | 1,209 | $8 | 101,807 (Indirect) | View |
| 2026-07-07 Exercise | 2026-07-17 06:03 am | 2023-10-06 N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director 10% Owner | 1,209 | $32 | 101,807 (Indirect) | View |
| 2026-06-24 Option Award | 2026-06-25 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 1,000 | $13 | 20,452 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 1,248 | $10.02 | 20,452 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 1,570 | $8.28 | 20,452 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 7,353 | $3.74 | 20,452 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 3,725 | $3.49 | 20,452 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 2,539 | $5.12 | 20,452 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 1,395 | $9.32 | 20,452 (Direct) | View |
| 2026-06-24 Option Award | 2026-06-25 8:04 pm | 2026-06-24 2036-04-01 | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 21,063 | $0 | 21,063 (Direct) | View |
| 2025-11-01 Option Award | 2025-11-04 5:00 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 58,619 | $0.75 | 26,619 (Direct) | View |
| 2025-10-22 Option Award | 2025-10-24 09:18 am | N/A N/A | Akari Therapeutics Plc | AKTX | Farag Kameel D. Interim CFO | 6,277 | $0.74 | 6,277 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-16 5:00 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 25,000 | $1.19 | 246,428 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 5:00 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 20,000 | $1.23 | 246,428 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer CEO | 20,000 | $1.27 | 201,428 (Direct) | View |
| 2025-03-06 Option Award | 2025-04-29 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 89,284 | $1.12 | 646,033 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Neal James R Director | 400,000 | $0 | 436,271 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 400,000 | $0 | 444,642 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 400,000 | $0 | 3,476,703 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 400,000 | $0 | 912,107 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 400,000 | $0 | 3,304,728 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner | 400,000 | $0 | 5,205,311 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Hombeck Torsten CFO | 500,000 | $0 | 500,200 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director | 1,700,000 | $0 | 1,881,428 (Direct) | View |